Actively Recruiting

Phase 4
Age: 18Years +
All Genders
Healthy Volunteers
NCT06406010

Investigating the Effect of Pericapsular Nerve Group (PENG) Block on Postoperative Pain After Peri-acetabular Osteotomy

Led by Matias Vested · Updated on 2025-08-26

90

Participants Needed

1

Research Sites

79 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The aim of this study is to determine the effect of PENG blockade on postoperative pain after either ropivacaine 5 mg/mL or saline (placebo) in patients undergoing PAO. The hypothesis of this study is that PENG block with ropivacaine reduces postoperative pain compared to placebo (saline).

CONDITIONS

Official Title

Investigating the Effect of Pericapsular Nerve Group (PENG) Block on Postoperative Pain After Peri-acetabular Osteotomy

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients 18 years or older
  • Provided informed consent
  • Scheduled for peri-acetabular osteotomy under general anesthesia with intubation
  • American Society of Anesthesiologists (ASA) physical status classification I to III
  • Can read and understand Danish
Not Eligible

You will not qualify if you...

  • Known allergy to ropivacaine
  • Daily use of opioids, gabapentin, or tricyclic antidepressants within the last four weeks before surgery
  • Contraindications to Celocoxib, NSAIDs, or paracetamol

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Rigshospitalet

Copenhagen, Denmark, 2100

Actively Recruiting

Loading map...

Research Team

M

Matias Vested

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

TRIPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here